Practical development of a novel method for hematopoietic stem cell expansion

造血干细胞扩增新方法的实际开发

• 批准号: 09357010
• 负责人: HIRAI Hisamaru
• 金额: $ 18.24万
• 依托单位: The University of Tokyo
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (A)
• 财政年份: 1997
• 资助国家: 日本
• 起止时间: 1997 至 1999
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-09357010/
• 关键词: Notch; DSL domain; Jagged1; differentiation; active Notch1; transcription factor; GATA-2; Notch1; Notch2; Notch3; EGF様リピート; 造血幹細胞; 自己複製能; ストローマ細胞; ES細胞; 遺伝子治療; CD34; アデノウイルス; EGF受容体; LTC-IC

The Delta/Serrate/LAG-2 (DSL) domain-containing proteins are considered to be ligands for Notch receptors. However, the physical interaction between DSL proteins and Notch receptors is poorly understood. We found that mJagged1 physically bound to mouse Notch2 (mNotch2) on the cell surface and to a purified extracellular portion of mNotch2, respectively, in a CaィイD22+-ィエD2dependent manner. Deletion mutant analyses showed that the DSL Domain of mJagged1 is a minimal binding unit and is indispensable for binding to mNotch2. The solid-phase binding assay showed that Jagged1 binds to Notch1 and Notch3 in addition to Notch2, suggesting that mJagged1 is a ligand for multiple Notch receptors. We further analyzed the expression levels of transcription factors, C/EBP α, C/EBPε, PU.1, AML1b, c-myb, and GATA-2 as myeloid-specific transcription factors, and SCL, GATA-1, GATA-2, NF-E2 (p45), MafK (p18), EKLF, and c-myb as erythroid-specific transcription factors, before and after stimulation for differentiation of the wild-type and aNotch1-expressing 32D myeloid cells and F5-5 erythroid cells, respectively. As a result, the expression levels of those transcription factors except GATA-2 showed the same pattern in the wild-type and aNotch1-expressing cells, whereas the expression level of GATA-2 was found unchanged after stimulation for differentiation in the aNotch1-expressing 32D cells but decreased in the wild-type cells, suggesting inhibition of differentiation by aNotch1 is mediated through GATA-2.

三角/锯齿/滞后-2（DSL）含有结构域的蛋白被认为是Notch受体的配体。但是，DSL蛋白与Notch受体之间的物理相互作用知之甚少。我们发现MJAGGED1在细胞表面上物理结合了小鼠Notch2（MNOTCH2），分别以caiy d22+-ie d2依赖性方式分别与mnotch2的纯化细胞外部分结合。缺失突变体分析表明，MJAGGED1的DSL结构域是一个最小的结合单元，对于与MNOTCH2的结合是必不可少的。固相结合测定表明，除Notch2外，JAGGED1与Notch1和Notch3结合，表明MJAGGED1是多个Notch受体的配体。我们进一步分析了转录因子的表达水平，C/EBPα，C/EBPε，PU.1，AML1B，C-MYB和GATA-2为髓样特异性转录因子，以及SCL，GATA-1，GATA-1，GATA-2，NF-E2，NF-E2（p45），MAFK（p18），EKLF（p18），EKLF和CYB和ERROFIFIC，ERROFIC，ERROFIC，ERROROFIC，ERROFRORID，并以前为了区分野生型和表达32D髓样细胞和F5-5红细胞细胞的分化。 As a result, the expression levels of those transcription factors except GATA-2 showed the same pattern in the wild-type and aNotch1-expressing cells, whereas the expression level of GATA-2 was found unchanged after stimulation for differentiation in the aNotch1-expressing 32D cells but decreased in the wild-type cells, suggesting inhibition of differentiation by aNotch1 is mediated through GATA-2.

项目成果

Kurokawa M: "The t (3 ; 21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks TGFβ-mediated growth inhibition of myeloid cells." Blood. 92. 4003-4012 (1998)

Kurokawa M：“t (3; 21) 融合产物 AML1/Evi-1 与 Smad3 相互作用并阻断 TGFβ 介导的骨髓细胞生长抑制。” Blood。

Tanaka K: "The AML1/ETO (MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2β (CBFβ) in the nucleus more efficiently than wild-type AML1." Blood. 91. 1688-1699 (1998)

Tanaka K：“AML1/ETO (MTG8) 和 AML1/Evi-1 白血病相关嵌合癌蛋白比野生型 AML1 更有效地在细胞核中积累 PEBP2β (CBFβ)。” 91. 1688-1699 (1998)

Honda H, Oda, H, Nakamoto T, Honda Z, Sakai R, Suzuki T, Saito T, Nakamura K, Nakao K, Ishikawa T, Katsuki M, Yazaki Y, Hirai H.: "Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas."Nature

Honda H、Oda、H、Nakamoto T、Honda Z、Sakai R、Suzuki T、Saito T、Nakamura K、Nakao K、Ishikawa T、Katsuki M、Yazaki Y、Hirai H.：“心血管异常、肌动蛋白成束和抵抗力受损

Takahasi T, Yamada K, Tanaka T, Kumano K, Kurokawa M, Takahashi T, Hirano N, Honda H, Chiba S, Tsuji K, Yazaki Y, Nakahata T, Hirai H.]: "A potential molecular approach to ex vivo hematopoietic expansion with recombinant EGFR-expressing adenovirus vector.

Takahasi T, Yamada K, Tanaka T, Kumano K, Kurokawa M, Takahashi T, Hirano N, Honda H, Chiba S, Tsuji K, Yazaki Y, Nakahata T, Hirai H.]：“体外造血的潜在分子方法

Chiba S: "Selective expression of mRNA coding for truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera." Blood. 90. 97-104 (1997)

Chiba S：“造血细胞中编码截短形式促红细胞生成素受体的 mRNA 的选择性表达及其在真性红细胞增多症患者中的减少。”